HCID 86700405, compound → HCID 86700410, compound

Participants

Reaction Steps

(2S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(2-(1-methyl-1H-indazol-5-yl)morpholino)benzo[d]thiazol-6-yl)acetic acid was prepared using the similar procedure as (2S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(2-(4-chlorophenyl)-2-methylmorpholino)-5-methylbenzo[d]thiazol-6-yl)acetic acid except 2-(1-methyl-1H-indazol-5-yl)morpholine was used instead of 2-(4-chlorophenyl)-2-methylmorpholine. LCMS-ESI+: calc'd for C32H33ClN4O4S: 605.2, 607.2 (M+H+); found: 605.3, 607.3 (M+H+). 1H-NMR: 400 MHz, (CD3OD) δ: 7.99 (s, 1H), 7.82 (s, 1H), 7.62 (d, J=7.6 Hz, 1H), 7.49-7.56 (m, 5H), 7.32 (s, 1H), 5.13 (s, 1H), 4.72 (d, J=7.2 Hz, 1H), 4.11 (m, 2H), 4.05 (s, 3H), 3.85 (m, 2H), 3.35 (m, 1H), 3.30 (t, J=12 Hz, 1H), 2.50 (s, 3H), 0.94 (s, 9H).

Provenance & Evidence